MedTrace Logo

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation

NCT01203904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301

Last updated 2016-06-07

No results posted yet for this study

Summary

The purpose of this study is to confirm the safety profile for long term treatment in children aged 5 years and \<15 years on bronchial asthma in daily clinical usage/Effect on growth rate. Effect on adrenal function. Development of infection diseases by diseases type.

Conditions

  • Bronchial Asthma

Sponsors & Collaborators

Principal Investigators

  • Shigeru Yoshida · AstraZenecaKK

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203904 on ClinicalTrials.gov